Recruiting Friedreich Ataxia Studies in Denver
About Friedreich Ataxia Clinical Trials in Denver
Friedreich ataxia is a rare inherited disease that causes progressive damage to the nervous system and movement problems. It is caused by reduced frataxin protein from a GAA repeat expansion. Treatment includes supportive care, with omaveloxolone recently approved.
There are currently 1 friedreich ataxia clinical trials recruiting participants in Denver, CO. These studies are seeking a combined 3,000 participants. Research is being sponsored by Friedreich's Ataxia Research Alliance. Clinical trial participation is free and participants receive study-related medical care at no cost.
Friedreich Ataxia Clinical Trials in Denver — FAQ
Are there friedreich ataxia clinical trials in Denver?
Yes, there are 1 friedreich ataxia clinical trials currently recruiting in Denver, CO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Denver?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Denver research site will contact you about next steps.
Are clinical trials in Denver free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Denver studies also compensate for your time and travel.
What friedreich ataxia treatments are being tested?
The 1 active trials in Denver are testing new therapies including novel drugs, biologics, and treatment approaches for friedreich ataxia.
Data updated October 17, 2026 from ClinicalTrials.gov